Schulman Amy W

Schulman Amy W is listed in filings as Director at Alnylam Pharmaceuticals Inc. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to Alnylam Pharmaceuticals Inc (ALNY), Elevance Health Inc (ELV), and Fractyl Health, Inc. Common Stock (GUTS). The current snapshot covers public activity from Jun 13, 2025 to May 22, 2026. Reported amounts are shown as $537.9K to $7.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.